Expert panel consensus recommendations on the utilization of nebulized budesonide for managing asthma and COPD in both stable and exacerbation stages in Thailand.
The Journal of asthma · 2024-03-25 · Guideline / consensus
Abstract
OBJECTIVE: This study investigated the utilization of nebulized budesonide for acute asthma and COPD exacerbations as well as for maintenance therapy in adults. DATA SOURCES: We conducted a search on PubMed for nebulized budesonide treatment. SELECTED STUDIES: Selecting all English-language papers that utilize Mesh phrases "asthma," "COPD," "budesonide," "nebulized," "adult," "exacerbation," and "maintenance" without temporal restrictions, and narrowing down to clinical research such as RCTs, observational studies, and real-world studies. RESULTS: Analysis of 25 studies was conducted to assess the effectiveness of nebulized budesonide in asthma (n = 10) and COPD (n = 15). The panel in Thailand recommended incorporating nebulized budesonide as an additional or alternative treatment option to the standard of care and systemic corticosteroids (SCS) based on the findings. CONCLUSION: Nebulized budesonide is effective and well-tolerated in treating asthma and COPD, with less systemic adverse effects compared to systemic corticosteroids. High-dose nebulized budesonide can enhance clinical outcomes for severe and mild exacerbations with slow systemic corticosteroid response. Nebulized budesonide can substitute systemic corticosteroids in some situations.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Corticosteroids · Inhaled corticosteroids · Respiratory drugs
Related articles
- Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial. (BMC Emerg Med, 2022)
- The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. (Ann Allergy Asthma Immunol, 2001)
- A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease. (Respir Med, 2016)
- Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. (Respir Med, 2000)
- A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room. (Sao Paulo Med J, 2022)
- Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. (Tuberk Toraks, 2006)